Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

PI3K plays a key role in cellular metabolism and cancer. Using a mass spectrometry-based metabolomics platform, we discovered that plasma concentrations of 26 metabolites, including amino acids, acylcarnitines, and phosphatidylcholines, were decreased in mice bearing PTEN-deficient tumors compared w...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Ang, Joo Ern, Pandher, Rupinder, Ang, Joo Chew, Asad, Yasmin J, Henley, Alan T, Valenti, Melanie, Box, Gary, de, Haven Brandon Alexis, Baird, Richard, Friedman, Lori, Derynck, Mika, Vanhaesebroeck, Bart, Eccles, Suzanne A, Kaye, Stan B, Workman, Paul, de, Bono Johann S, Raynaud, Florence I
Altri autori:	Antwerp X-ray Analysis, Electrochemistry and Speciation (AXES)
Lingua:	inglese
Pubblicazione:	American Association for Cancer Research 2019
Accesso online:	https://demo7.dspace.org/handle/123456789/449
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!